FDA Will Not Require Premarket Review of Lab-Developed Tests Without Rulemaking, HHS Says
- August 21, 2020
The Department of Health and Human Services (HHS) announced August 19 that the Food and Drug Administration (FDA) will not require premarket review of laboratory developed tests (LDT) absent notice-and-comment rulemaking.
ARTICLE TAGS
You must be logged in to access this content.